Cannabis Law Report

AUGUST 25, 2021

Q1 Operational Highlights: Expansion into the topicals market with an exclusive manufacturing and distribution agreement with MapleX (announced April 13, 2021), which has become the Company’s partner for Amazon and Walmart on-line sales. Common shares – basic. . . 100,666,805. . 77,067,435.

Events 111

Events Pharmaceutical Research and Development Business 111

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

DECEMBER 1, 2021

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. She believes that integration is a life-long practice, and strives to live life with integrated spirit and body.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

DECEMBER 9, 2021

BEYOND / HELLO™ Pittsburgh will provide customers with an efficient, accessible, and safe experience that goes beyond the traditional cannabis retail environment. The dispensary will carry dry leaf, concentrates, cartridges, tinctures, topicals, capsules, pills and various ancillary products such as approved batteries and devices.

Dispensary 52

Dispensary Retail Patients Events 52

Cannabis Law Report

NOVEMBER 29, 2021

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Please refer to the Company’s public record on SEDAR at www.sedar.com for more details on the risks faced by the Company.

Extraction 52

Extraction Cannabinoids Research and Development Vaping 52

Cannabis Law Report

NOVEMBER 25, 2021

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Please refer to the Company’s public record on SEDAR at www.sedar.com for more details on the risks faced by the Company.

Terpenes 52

Terpenes Vaping Topical Cannabinoids 52

Cannabis Law Report

SEPTEMBER 23, 2021

(the “ Company ” or “ Hempsana ”) is excited to announce that the Company has received approval from Health Canada to amend their cannabis licence to authorize the activity of sale of cannabis extracts, beverages, edibles, and topical products. READER ADVISORY. Director and Chief Executive Officer. T: (647) 255-8849. E: randy@hempsana.ca.

Extraction 52

Extraction Topical Edibles Cannabinoids 52

Cannabis Law Report

MARCH 17, 2022

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Please refer to the Company’s public record on SEDAR at www.sedar.com for more details on the risks faced by the Company.

Tincture 52

Tincture Vaping Topical Cannabinoids 52

Cannabis Law Report

JANUARY 10, 2022

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Please refer to the Company’s public record on SEDAR at www.sedar.com for more details on the risks faced by the Company.

Terpenes 52

Terpenes Cannabinoids Extraction Research and Development 52

Cannabis Law Report

SEPTEMBER 20, 2021

Embark is also equipped to produce a range of cannabis concentrates, liquid and powder beverage mixes, topicals and edible products. Embark Delta is federally licensed and is actively producing concentrates, beverage mixes and topicals. The Hank Hash – High quality, accessible concentrates. Embark Delta is a 40,000 sq.

Hash 52

Hash Seed-To-Sale Research and Development Topical 52

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. Results of an observational study merely suggest an association between a therapeutic agent or an event and an outcome. Le-Short C.,

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 17, 2021

We received quite a few requests from our large network of retail investors, brokers, and funds, to allow further access into this small strategic private placement,” commented Dr. Jason Mitchell, HempFusion’s Co-founder and Chief Executive Officer.

Research and Development 52

Research and Development Events Retail Tincture 52

The Cannigma

OCTOBER 25, 2021

Canadian law allows people to receive medical cannabis for any condition or symptoms approved by their personal healthcare practitioner. The government store also has an extensive range of concentrates, vape cartridges, topicals, and edibles, including gummies, chocolates, cookies, and beverages. products in Canada. billion ($5.16

Legalization 106

Legalization Packaging Edibles Retail 106

Cannabis Law Report

NOVEMBER 1, 2021

The Transaction is scheduled to close on or about November 15, 2021 , and subject to customary closing conditions and covenants. portfolio and gain access to its product development expertise and formulation lab capabilities. Closing of the Transaction is subject to customary closing conditions and the approval of the CSE.

Research and Development 52

Research and Development Edibles Vaping Seed-To-Sale 52

Cannabis Law Report

NOVEMBER 29, 2021

with their product portfolio including Multicannabinoid™ tinctures, softgels, and topicals. The location is also easily-accessible from Deerfoot Trail, which is Calgary’s most heavily-used freeway. It has quickly grown to become one of the most popular brands for premium cannabinoid wellness products across the U.S.,

Retail 52

Retail Cannabinoids Events Recreational 52

SpeedWeed

MARCH 19, 2021

The legality of psychedelics is a complex topic in most countries due to various drug laws that ban people from using and possessing them. The recent events in Canada suggest that the country could be the next North American country with a psychedelic-friendly environment, particularly for medical use. View original article.

Environment 52

Environment Decriminalization Research and Development Advocacy 52

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Delta-8 is known to be successful in many cancer treatments.”. Website etiquette.

THC 52

THC CBD Media Food 52

CannaMD

DECEMBER 9, 2020

Little time will be devoted to opening sections which cover well-documented topics such as historic and current cannabis use, definitions, formulations, pharmacokinetics, pharmacodynamics, and policies on use. The authors also caution against the consumption of certain over-the-counter topical CBD products which do not fall under the U.S.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Puff Puff Post

SEPTEMBER 24, 2019

the Emperor Shen Nung prescribed cannabis for various medical conditions such as gout, rheumatism, and poor memory. includes the use of cannabis for treating inflammatory conditions. . On July 30 th , 2001, the government brought this into a legislative act known as the Medical Marijuana Access and Resources (MMAR). In 2723 B.C.,

History 94

History Cannabinoids Indica Tincture 94

Cannabis Law Report

OCTOBER 12, 2021

Terry Booth, AUSA CEO, stated, “DelMorgan is a highly regarded name with broad access to institutional investors active in the cannabis industry, our target audience for this raise. Under the partnership, the Company is launching a PBR endorsed line of topical CBD products under the Wreck Relief brand.

Supply Chain 52

Supply Chain Conditions Events Business 52

Cannabis Law Report

JUNE 10, 2021

The initial focus is on two product verticals: premium skincare and topical athletic recovery products to be launched from this autumn. -based provider of premium consumer products based on biosynthetic cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid products.

Research and Development 66

Research and Development Cannabinoids Pharmaceutical Policy 66

The Joint Blog

AUGUST 8, 2023

While much attention has been focused on the well-known compounds like CBD and Delta-9-THC, a lesser-known cannabinoid called Delta-8-THC has emerged as a topic of interest. Nevertheless, experts, including medical professionals and legislators, have raised concerns about the unregulated production and accessibility of delta-8 THC products.

Cannabinoids 26

Cannabinoids THC Packaging Safety 26

PrestoDoctor

OCTOBER 3, 2018

The government is trying to allow vets to be able to use cannabis and give ’em more access to cannabis. The most notable sporting event to kick off the change was the recently concluded World Cup in Russia. He told CBS Sports , “Over the last couple of days, there’s been a lot of announcements and stuff like that.

CBD 79

CBD Strains Oil Pharmaceutical 79

Project CBD

FEBRUARY 28, 2023

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. The labs analyzed 35 oils, 40 topical products, 40 edibles, 22 beverages, 55 pet products, and 29 coffee or tea products.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 1, 2021

33%. – Beverages, edibles, topicals. and vapes. 14%. – Beverages, edibles, topicals. and vapes. A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. Canadian recreational cannabis. – Dry bud[8]. – – Oils and softgels8.

Data 95

Data Vaping Supply Chain Business 95

Healer

NOVEMBER 15, 2023

In this article, I’ll review what we know and don’t know about the new findings (including some juicy details that didn’t make it to the media reports), compare with some of the previous publications on this topic, and boil it down to what matters for people with cardiovascular disease or cardiovascular risks who want to safely use cannabis.

Data 126

Data Topical Conditions Research and Development 126

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.

History 119

History Microdosing Research and Development Clinical Trials 119

MedicalJane

DECEMBER 6, 2017

New York Governor Andrew Cuomo marked this past Veteran’s Day by signing a measure that expanded the state’s medical cannabis qualifying conditions to include post-traumatic stress disorder (PTSD). The Governor has been conservative on the issue with a self-described “ open mind ” since the topic arose a few years ago.

Programs 47

Programs Legislation Patients Education 47

Cannabis Law Report

SEPTEMBER 12, 2019

We are focused on building a sustainable, high-margin business while providing patients and consumers with access to safe and reliable medicine.” Subsequent Events. 1) Cannabis extracts revenue includes cannabis oils, capsules, softgels, sprays, and topical revenue. ($ thousands). Adjusted EBITDA loss of $11.7

Research and Development 45

Research and Development Extraction Cannabis Wellness and Beauty 45

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Marijuana and CBD are most commonly used via inhalation, ingestion, and topical absorption. 17 Topical cannabis is applied to, and absorbed through, the skin in a cream or salve form.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? I’ve seen it as flower, I’ve seen it as topical, which has anti-bacterial and anti-psoriatic effects. Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

OCTOBER 24, 2021

Specifically, we will discuss the challenges and key considerations when attempting to quantify the lost profits that can arise from either first-party exposure from an insured event or third-party claims. On August 24, 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) replaced the MMPR 2. “Cannabis 2.0”

Strains 52

Strains Edibles Extraction Vaping 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JANUARY 3, 2023

Some studies suggest that chronic exposure to cannabinoids may cause menstrual cycle disruption, but this is a topic of debate. A 2016 study examined endocannabinoid levels in women with and without endometriosis, a condition that causes painful periods due to growth on the outside of the uterus. Best terpenes for period pain.

Terpenes 106

Terpenes Strains Oil THC 106

The Joint Blog

MAY 13, 2020

So we reached out to Eloise Theisen , RN, MSN, AGPCNP-BC, Pacific College of Health and Science faculty ( Medical Cannabis program ), and President of the American Cannabis Nurse Association to get her take on topic. Different products will vary in onset and duration and the consumer may use a tincture pre-workout and a topical post workout.

Blood Pressure 52

Blood Pressure Tincture Cannabinoids Topical 52

Cannabis Law Report

AUGUST 6, 2021

THC market already exist for the Company, including immediate path through planned acquisition of Acreage Holdings and conditional ownership of TerrAscend, which provides further optionality to increase presence. Beverages, edibles, topicals 7. and vapes. Beverages, edibles, topicals. and vapes. Excise taxes.

Vaping 105

Vaping Research and Development Data Business 105